insights_auto
Why is DNLI up 2.89%?
Dive Deeperchevron_right
DNLI:NASDAQ
Denali Therapeutics Inc
$20.98
arrow_upward
+2.89%(+0.59) 1D
$21.00
arrow_upward
+0.10% (+0.020)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNLI...
Open
$20.05
High
$21.26
Low
$19.93
Mkt. cap
3.35B
Avg. vol.
1.42M
Volume
256.00
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.01
Shares outstanding
159.85M
No. of employees
507
Open
$20.05
High
$21.26
Low
$19.93
Mkt. cap
3.35B
Avg. vol.
1.42M
Volume
256.00
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.01
Shares outstanding
159.85M
No. of employees
507
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
DNLI Q1 2026 Earnings: Narrower Loss of $0.69 per Share Beats Estimates, Yet Stock Slips 5.46% - Revenue Recognition Risk
About Denali Therapeutics Inc
CEO-
Employees507
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitedenalitherapeutics.com